Effect of long-term antihypertensive and hypolipidemic treatment on high density lipoprotein cholesterol and apolipoproteins A-I and A-II
- 1 June 1980
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 36 (2), 249-259
- https://doi.org/10.1016/0021-9150(80)90233-6
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Diet and probucol in lowering cholesterol concentrations. Additive effects on plasma cholesterol concentrations in patients with familial type ii hyperlipoproteinemiaArchives of Internal Medicine, 1977
- The Measurement of Apolipoprotein A-I and A-II Levels in Men and Women by ImmunoassayJCI Insight, 1977
- HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study.Circulation, 1977
- High density lipoprotein as a protective factor against coronary heart diseaseThe American Journal of Medicine, 1977
- THE TROMSØHEART-STUDYThe Lancet, 1977
- Probucol: A new cholesterol‐lowering drug effective in patients with type II hyperlipoproteinemiaClinical Pharmacology & Therapeutics, 1976
- Effect of chronic administration of propranolol on lipoprotein compositionMetabolism, 1976
- Quantitation of apolipoprotein A-I of human plasma high density lipoproteinMetabolism, 1976
- A MECHANISM BY WHICH HIGH-DENSITY LIPOPROTEINS MAY SLOW THE ATHEROGENIC PROCESSThe Lancet, 1976
- Measurement of human high density lipoprotein apolipoprotein A-I in serum by radioimmunoassayJournal of Lipid Research, 1976